Item Type | Name |
Concept
|
Exercise Therapy
|
Concept
|
Drug Therapy
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Treatment Outcome
|
Concept
|
Thrombolytic Therapy
|
Concept
|
Estrogen Replacement Therapy
|
Concept
|
Cardiac Resynchronization Therapy
|
Concept
|
Time-to-Treatment
|
Academic Article
|
Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
|
Academic Article
|
Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States.
|
Academic Article
|
The risk of cardiovascular side effects with anti-anginal drugs.
|
Academic Article
|
Drug Therapy for Stable Angina Pectoris.
|
Academic Article
|
Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence.
|
Academic Article
|
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group.
|
Academic Article
|
Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial.
|
Academic Article
|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
|
Academic Article
|
Beta blockers in hypertension.
|
Academic Article
|
Short and long-acting oral nitrates for stable angina pectoris.
|
Academic Article
|
Nitrates for unstable angina.
|
Academic Article
|
Treatment of stable angina.
|
Academic Article
|
Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction.
|
Academic Article
|
Therapy of stable angina pectoris: the uncomplicated patient.
|
Academic Article
|
Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes.
|
Academic Article
|
Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients.
|
Academic Article
|
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
|
Academic Article
|
Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies.
|
Academic Article
|
Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study.
|
Academic Article
|
Utilization of guideline-directed medical therapy in patients with de novo heart failure with reduced ejection fraction: A Veterans Affairs study.
|
Academic Article
|
Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.
|
Academic Article
|
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
|
Academic Article
|
Medical therapy of stable angina pectoris.
|
Academic Article
|
Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance.
|
Academic Article
|
Nitrate therapy: continuous or pulse dosing.
|
Academic Article
|
Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
|
Academic Article
|
Mononitrates: defining the ideal long-acting nitrate.
|
Academic Article
|
Duration of effects of isradipine during twice daily therapy in angina pectoris.
|
Academic Article
|
Conversion from immediate-release to extended-release diltiazem in angina pectoris.
|
Academic Article
|
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
|
Academic Article
|
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
|
Academic Article
|
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
|
Academic Article
|
Choosing the most appropriate treatment for stable angina. Safety considerations.
|
Academic Article
|
Current medical management of chronic stable angina.
|
Academic Article
|
A multicenter comparison of isradipine and prazosin for treatment of essential hypertension.
|
Academic Article
|
Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Academic Article
|
Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.
|
Academic Article
|
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
|
Academic Article
|
Is risk factor control and guideline-based medical therapy optimal in patients with nonobstructive coronary artery disease? A Veterans Affairs study.
|
Academic Article
|
Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance.
|
Academic Article
|
Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
|
Academic Article
|
Propranolol in angina pectoris: comparison of therapy given two and four times daily.
|
Academic Article
|
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
|
Academic Article
|
Nitrate therapy and the development of tolerance.
|
Academic Article
|
Secondary preventive potential of nitrates in ischaemic heart disease.
|
Academic Article
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
|
Academic Article
|
Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.
|
Academic Article
|
Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
|
Academic Article
|
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
|
Academic Article
|
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Academic Article
|
Selection of optimal therapy for chronic stable angina.
|
Academic Article
|
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Academic Article
|
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
|
Academic Article
|
The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis.
|
Academic Article
|
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
|
Academic Article
|
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
|
Academic Article
|
Editorial commentary: Treatment of refractory angina: An ongoing challenge.
|
Academic Article
|
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.
|
Academic Article
|
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study.
|
Academic Article
|
Chronic stable angina pectoris. Strategies for effective drug therapy.
|
Academic Article
|
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study Group.
|
Academic Article
|
Oral nitrates: more than symptomatic therapy in coronary artery disease?
|
Academic Article
|
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.
|
Academic Article
|
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
|